The first week of March signified an amazing new discovery for anti aging enthusiasts. An enzyme, SIRT1, is believed to be the ultimate triggering enzyme that will help maintain your younger looking skin. Moreover, it has also been seen as a major deterrent against cancer, type 2 diabetes, and cancer, which is popularly experience by the older members of society.
Professor David Sinclair of UNSW Medicine excitedly announced this discovery to the public. He claims this to be the secret drug, which will slow down the aging process; but there is still more to learn, test, and discover about this unique enzyme. Moreover, activators have to be used to easily trigger the anti aging properties of this enzyme; one of which is resveratrol.
Resveratrol remains to be the best activator for tweaking of enzymes and it has been associated with the cure and prevention of other diseases like sleep disorders, liver diseases, Parkinson’s diseases, arthritis, colitis, and cardiac failure. Due to this, approximately 4000 synthetic activators have already been produced mimicking the properties of resveratrol. Some are even 100 times more potent than the natural activator itself.
The above-mentioned technology was already sold to GlaxoSmithKline in the year 2008. However, it will still take another five years before the drug could be available as more research study is conducted by the company. Once approved, the drug could be administered topically or orally. Nevertheless, the drug is still at the initial stage and many are excited to hear how it will bring benefit to the senior community in the future.
If you are interested to learn more about the study conducted by Professor Sinclair and GlaxoSmithKline, read http://www.sciencedaily.com/releases/2013/03/130308111312.htm and be updated with the latest anti aging news and products around the globe.